367 related articles for article (PubMed ID: 3813503)
1. The pathophysiology of penicillamine-induced myasthenia gravis.
Kuncl RW; Pestronk A; Drachman DB; Rechthand E
Ann Neurol; 1986 Dec; 20(6):740-4. PubMed ID: 3813503
[TBL] [Abstract][Full Text] [Related]
2. Acetylcholine receptor antibody characteristics in myasthenia gravis. II. Patients with penicillamine-induced myasthenia or idiopathic myasthenia of recent onset.
Vincent A; Newsom-Davis J
Clin Exp Immunol; 1982 Aug; 49(2):266-72. PubMed ID: 7127905
[TBL] [Abstract][Full Text] [Related]
3. [D-penicillamine-induced myasthenia gravis].
Frey RA; Keller F; Michel BA
Schweiz Med Wochenschr; 1994 May; 124(20):852-6. PubMed ID: 8209208
[TBL] [Abstract][Full Text] [Related]
4. Anti-MuSK- and anti-AChR-positive myasthenia gravis induced by d-penicillamine.
Poulas K; Koutsouraki E; Kordas G; Kokla A; Tzartos SJ
J Neuroimmunol; 2012 Sep; 250(1-2):94-8. PubMed ID: 22683336
[TBL] [Abstract][Full Text] [Related]
5. Fine antigenic specificities of antibodies in sera from patients with D-penicillamine-induced myasthenia gravis.
Tzartos SJ; Morel E; Efthimiadis A; Bustarret AF; D'Anglejan J; Drosos AA; Moutsopoulos HA
Clin Exp Immunol; 1988 Oct; 74(1):80-6. PubMed ID: 2464451
[TBL] [Abstract][Full Text] [Related]
6. Penicillamine-induced ocular myasthenia gravis in rheumatoid arthritis.
Liu GT; Bienfang DC
J Clin Neuroophthalmol; 1990 Sep; 10(3):201-5. PubMed ID: 2144538
[TBL] [Abstract][Full Text] [Related]
7. D-Penicillamine-associated myasthenia gravis: immunological and electrophysiological studies.
Fawcett PR; McLachlan SM; Nicholson LV; Argov Z; Mastaglia FL
Muscle Nerve; 1982 Apr; 5(4):328-34. PubMed ID: 7099199
[TBL] [Abstract][Full Text] [Related]
8. Antigenic modulation of junctional acetylcholine receptor is not sufficient to account for the development of myasthenia gravis in receptor immunized mice.
Berman PW; Heinemann SF
J Immunol; 1984 Feb; 132(2):711-7. PubMed ID: 6690616
[TBL] [Abstract][Full Text] [Related]
9. [Myasthenia gravis syndrome following administration of d-penicillamine (author's transl)].
Rousseau JJ; Dieudonne LG
Acta Neurol Belg; 1980; 80(3):165-73. PubMed ID: 7457085
[TBL] [Abstract][Full Text] [Related]
10. Anti-MuSK patient antibodies disrupt the mouse neuromuscular junction.
Cole RN; Reddel SW; Gervásio OL; Phillips WD
Ann Neurol; 2008 Jun; 63(6):782-9. PubMed ID: 18384168
[TBL] [Abstract][Full Text] [Related]
11. [Myasthenic syndrome induced by D-penicillamine. Changes in serum levels of acetylcholine receptor antibodies].
Woimant F; Benacin L; Delauche MC; Haguenau M; Pepin B
Nouv Presse Med; 1982 May; 11(23):1807-8. PubMed ID: 7099959
[No Abstract] [Full Text] [Related]
12. The in vitro effects of D-penicillamine upon anti-AChR production by thymic and peripheral blood lymphocytes from patients with myasthenia gravis.
Scadding GK; Calder L; Newsom-Davis J
Muscle Nerve; 1983; 6(9):656-60. PubMed ID: 6606776
[TBL] [Abstract][Full Text] [Related]
13. D-penicillamine-induced myasthenia gravis in primary biliary cirrhosis.
Marcus SN; Chadwick D; Walker RJ
Gastroenterology; 1984 Jan; 86(1):166-8. PubMed ID: 6689658
[TBL] [Abstract][Full Text] [Related]
14. Penicillamine induced polymyositis and dermatomyositis.
Carroll GJ; Will RK; Peter JB; Garlepp MJ; Dawkins RL
J Rheumatol; 1987 Oct; 14(5):995-1001. PubMed ID: 3501473
[TBL] [Abstract][Full Text] [Related]
15. [Acetylcholine receptor antibody in D-penicillamine therapy].
Kolarz G; Maida EM
Z Rheumatol; 1986; 45(3):118-21. PubMed ID: 3751350
[TBL] [Abstract][Full Text] [Related]
16. Lewis rats given antibodies against denatured acetylcholine receptor become resistant to induction of experimental autoimmune myasthenia gravis.
Krolick KA; Yeh TM; Edlund SA
Cell Immunol; 1996 Aug; 172(1):10-20. PubMed ID: 8806801
[TBL] [Abstract][Full Text] [Related]
17. [Antibodies in myasthenia gravis].
Eymard B
Rev Neurol (Paris); 2009 Feb; 165(2):137-43. PubMed ID: 19162288
[TBL] [Abstract][Full Text] [Related]
18. HLA antigens and acetylcholine receptor antibodies in penicillamine induced myasthenia gravis.
Garlepp MJ; Dawkins RL; Christiansen FT
Br Med J (Clin Res Ed); 1983 Jan; 286(6362):338-40. PubMed ID: 6402089
[TBL] [Abstract][Full Text] [Related]
19. Augmented anti-acetylcholine receptor response following long-term penicillamine administration.
Bever CT; Dretchen KL; Blake GJ; Chang HW; Penn AS; Asofsky R
Ann Neurol; 1984 Jul; 16(1):9-13. PubMed ID: 6431900
[TBL] [Abstract][Full Text] [Related]
20. [Penicillamine-induced myasthenia gravis].
Nishida H; Sahashi K
Ryoikibetsu Shokogun Shirizu; 2001; (36):351-3. PubMed ID: 11596408
[No Abstract] [Full Text] [Related]
[Next] [New Search]
